BridgeMD
New treatment option for Infertility, Female
Official title Uterus Transplantation From a Multi-organ Donor
ClinicalTrials.gov ID: NCT03252795
What this study is testing
- What it's testing
- Uterus transplantation: screening, in vitro fertilization [IVF] treatment to be able to freeze embryos, uterus transplantation, pregnancy and afterwards removal of the uterus.
A plain-language read of the study's public ClinicalTrials.gov listing. The study team confirms the details.
Who can take part
Ages 18 to 38, women only
You may be able to join if
- Female with Maier-Rokitansky-Kuster-Hauser syndrome
- Mucosal neovagina of at least 7 cm
- In a stable relationship for at least 1 year
- Child wish
- Good renal function (and presence of both kidneys)
You likely can't join if
- Major pelvic surgery
- Major chronic illnesses
- Other risk factors or malignancies
- BMI \> 30
See the full eligibility criteria
- Female with Maier-Rokitansky-Kuster-Hauser syndrome
- Mucosal neovagina of at least 7 cm
- In a stable relationship for at least 1 year
- Child wish
- Good renal function (and presence of both kidneys)
- Psychologically stable and compliant
- At least 8 frozen embryos after IVF/intracytoplasmic sperm injection [ICSI]
- Living in Belgium and a good health insurance
- Willing and able to provide informed consent
- Major pelvic surgery
- Major chronic illnesses
- Other risk factors or malignancies
- BMI \> 30
The study team makes the final eligibility decision.
Where it's taking place
- Ghent, Belgium
Questions & answers
Do participants get paid in this trial?
This listing doesn't specify compensation. Many trials still reimburse travel or offer a stipend, so it's worth asking the study team when you connect.
Is it free to join, and do I need insurance?
Searching and applying through BridgeMD is free. In clinical trials the study-related treatment and visits are generally provided at no cost to you. You usually don't need insurance to take part - confirm specifics with the study team.
How long does this study last?
The listing doesn't state an exact length. The study team walks you through the schedule and number of visits before you decide to enroll.
Who can join this trial?
This study is enrolling female, 18 years to 38 years. The study team makes the final eligibility decision.
Where is this trial taking place?
Study sites include Ghent, Belgium. Enter your location above to see the nearest site and check your eligibility.
Explore other conditions
BridgeMD is an information and trial-matching tool - not medical advice, and not the study sponsor. Details come from ClinicalTrials.gov; the study team decides eligibility.